Pub Date : 2022-05-31DOI: 10.17269/s41997-022-00657-1
S. MacDonald, L. Reifferscheid, J. Bettinger, J. Robinson, M. Sadarangani, È. Dubé, N. MacDonald, E. K. Marfo, A. Assi, A. Gagneur, S. Driedger
Dear Editor: We thank Sookaromdee and Wiwanitkit (2022) for their letter to the Editor, and agree with the authors’ point that the influences on vaccine hesitancy and vaccine decisionmaking during pregnancy are multifaceted. However, we disagree with the emphasis they place on sociodemographic factors. Our finding of vaccine safety concerns as a primary driver of vaccine acceptance/hesitancy among pregnant people is well supported by the literature, as cited in our paper (Reifferscheid et al., 2022). Conversely, sociodemographic factors have not been found to be universally significant determinants of vaccine decisions (Nikpour et al., 2022), but are instead indicators of the context in which vaccine decisions are made. Even in settings where sociodemographic factors are significant, information on the risks and benefits of vaccination, tailored to the literacy and numeracy skills of pregnant individuals, is still required (Skirrow et al., 2022). We also think it is important to note that the vaccine decision-making process during pregnancy is unique, because the vaccine impacts both the pregnant individual and their unborn infant. Therefore, studies of the general population, such as those cited by Sookaromdee and Wiwanitkit (Khan et al., 2022; Xiao et al., 2022), should not be considered representative of the pregnant population. Sookaromdee and Wiwanitkit also note that our study was conducted at one specific point in time and that no firm conclusions should be made from an individual study. These are observations that we do not dispute. Rather than advocating for a static approach, the goal of our paper was to emphasize the importance of continuing to explore potential strategies to support pregnant people and their healthcare providers in vaccine decision-making.
亲爱的编辑:我们感谢Sookaromdee和Wiwanitkit(2022)给编辑的信，并同意作者的观点，即怀孕期间对疫苗犹豫和疫苗决策的影响是多方面的。然而，我们不同意他们对社会人口因素的强调。我们发现疫苗安全问题是孕妇疫苗接受/犹豫的主要驱动因素，这一发现得到了文献的充分支持，正如我们的论文所引用的那样(Reifferscheid et al.， 2022)。相反，社会人口因素并没有被发现是疫苗决策的普遍重要决定因素(Nikpour等人，2022年)，而是做出疫苗决策的背景指标。即使在社会人口因素显著的情况下，仍然需要根据孕妇的识字和计算技能，提供有关疫苗接种风险和益处的信息(Skirrow等人，2022年)。我们还认为，必须注意到，怀孕期间的疫苗决策过程是独特的，因为疫苗既影响孕妇，也影响未出生的婴儿。因此，对一般人群的研究，如Sookaromdee和Wiwanitkit (Khan et al.， 2022;Xiao et al.， 2022)，不应该被认为是怀孕人群的代表。Sookaromdee和Wiwanitkit还指出，我们的研究是在一个特定的时间点进行的，不应该从个人研究中得出确切的结论。这些都是我们没有异议的观察结果。我们论文的目的不是提倡一种静态的方法，而是强调继续探索潜在策略的重要性，以支持孕妇及其医疗保健提供者进行疫苗决策。
{"title":"Authors’ response: Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”","authors":"S. MacDonald, L. Reifferscheid, J. Bettinger, J. Robinson, M. Sadarangani, È. Dubé, N. MacDonald, E. K. Marfo, A. Assi, A. Gagneur, S. Driedger","doi":"10.17269/s41997-022-00657-1","DOIUrl":"https://doi.org/10.17269/s41997-022-00657-1","url":null,"abstract":"Dear Editor: We thank Sookaromdee and Wiwanitkit (2022) for their letter to the Editor, and agree with the authors’ point that the influences on vaccine hesitancy and vaccine decisionmaking during pregnancy are multifaceted. However, we disagree with the emphasis they place on sociodemographic factors. Our finding of vaccine safety concerns as a primary driver of vaccine acceptance/hesitancy among pregnant people is well supported by the literature, as cited in our paper (Reifferscheid et al., 2022). Conversely, sociodemographic factors have not been found to be universally significant determinants of vaccine decisions (Nikpour et al., 2022), but are instead indicators of the context in which vaccine decisions are made. Even in settings where sociodemographic factors are significant, information on the risks and benefits of vaccination, tailored to the literacy and numeracy skills of pregnant individuals, is still required (Skirrow et al., 2022). We also think it is important to note that the vaccine decision-making process during pregnancy is unique, because the vaccine impacts both the pregnant individual and their unborn infant. Therefore, studies of the general population, such as those cited by Sookaromdee and Wiwanitkit (Khan et al., 2022; Xiao et al., 2022), should not be considered representative of the pregnant population. Sookaromdee and Wiwanitkit also note that our study was conducted at one specific point in time and that no firm conclusions should be made from an individual study. These are observations that we do not dispute. Rather than advocating for a static approach, the goal of our paper was to emphasize the importance of continuing to explore potential strategies to support pregnant people and their healthcare providers in vaccine decision-making.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"14 1","pages":"560 - 561"},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84056560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-26DOI: 10.17269/s41997-022-00648-2
A. De Waal, C. Racey, R. Donken, Kara M. Plotnikoff, S. Dobson, L. Smith, T. Grennan, M. Sadarangani, G. Ogilvie
The aim of this study was to explore the acceptability of bacterial STI vaccines among young HPV-vaccinated Canadian women to inform future vaccine program implementation. A 20-item cross-sectional questionnaire was administered from June 2019 to June 2020 to HPV-vaccinated participants of the pan-Canadian QUEST cohort. Multivariable logistic regression models assessed interest in chlamydia, syphilis, and gonorrhea vaccines using a priori variables and factors significant in bivariate analysis. Of the 1092 respondents analyzed, 82% indicated interest in receiving one or more future STI vaccines. Respondents had a median age of 19.6 years (range 16.9–23.4), and 75% of respondents identified as white/European descent. In adjusted analyses, intent to engage in positive health behaviours was associated with vaccine interest for syphilis (OR = 5.76, 95% CI 4.03–8.27), chlamydia (OR = 5.27, 95% CI 3.66–7.63), and gonorrhea (OR = 5.96, 95% CI 4.15–8.60). Willingness to pay for an STI vaccine was also associated with vaccine interest for syphilis (OR = 2.02, 95% CI 1.29–3.19), chlamydia (OR = 2.41, 95% CI 1.50–3.90), and gonorrhea (OR = 2.29, 95% CI 1.44–3.63). Ever having sexual intercourse and identifying as LGBTQ were significantly associated with vaccine interest for all infections, while age and ever being immunosuppressed were not significant in any adjusted models. Findings indicate over 80% of participants in a cohort of young HPV-vaccinated Canadian women are interested in receiving future bacterial STI vaccines. Further exploration of STI vaccine acceptability among diverse populations is required to inform future bacterial STI vaccine program implementation.
本研究的目的是探讨在接种hpv疫苗的加拿大年轻妇女中细菌性传播感染疫苗的可接受性，为未来疫苗计划的实施提供信息。从2019年6月至2020年6月，对泛加拿大QUEST队列中接种hpv疫苗的参与者进行了一份20项横断面问卷调查。多变量logistic回归模型评估了对衣原体、梅毒和淋病疫苗的兴趣，使用了先验变量和双变量分析中显著的因素。在分析的1092名答复者中，82%表示有兴趣今后接种一种或多种性传播感染疫苗。受访者的中位年龄为19.6岁(16.9-23.4岁)，75%的受访者为白人/欧洲血统。在调整分析中，参与积极健康行为的意愿与梅毒(OR = 5.76, 95% CI 4.03-8.27)、衣原体(OR = 5.27, 95% CI 3.66-7.63)和淋病(OR = 5.96, 95% CI 4.15-8.60)的疫苗兴趣相关。购买性传播感染疫苗的意愿也与梅毒(OR = 2.02, 95% CI 1.29-3.19)、衣原体(OR = 2.41, 95% CI 1.50-3.90)和淋病(OR = 2.29, 95% CI 1.44-3.63)的疫苗兴趣相关。曾经有过性行为和LGBTQ身份与所有感染的疫苗兴趣显著相关，而年龄和曾经免疫抑制在任何调整后的模型中都不显著。研究结果表明，在接种hpv疫苗的加拿大年轻女性队列中，超过80%的参与者有兴趣接受未来的细菌性传播感染疫苗。需要进一步探索不同人群对性传播感染疫苗的可接受性，以便为未来细菌性传播感染疫苗规划的实施提供信息。
{"title":"Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women","authors":"A. De Waal, C. Racey, R. Donken, Kara M. Plotnikoff, S. Dobson, L. Smith, T. Grennan, M. Sadarangani, G. Ogilvie","doi":"10.17269/s41997-022-00648-2","DOIUrl":"https://doi.org/10.17269/s41997-022-00648-2","url":null,"abstract":"The aim of this study was to explore the acceptability of bacterial STI vaccines among young HPV-vaccinated Canadian women to inform future vaccine program implementation. A 20-item cross-sectional questionnaire was administered from June 2019 to June 2020 to HPV-vaccinated participants of the pan-Canadian QUEST cohort. Multivariable logistic regression models assessed interest in chlamydia, syphilis, and gonorrhea vaccines using a priori variables and factors significant in bivariate analysis. Of the 1092 respondents analyzed, 82% indicated interest in receiving one or more future STI vaccines. Respondents had a median age of 19.6 years (range 16.9–23.4), and 75% of respondents identified as white/European descent. In adjusted analyses, intent to engage in positive health behaviours was associated with vaccine interest for syphilis (OR = 5.76, 95% CI 4.03–8.27), chlamydia (OR = 5.27, 95% CI 3.66–7.63), and gonorrhea (OR = 5.96, 95% CI 4.15–8.60). Willingness to pay for an STI vaccine was also associated with vaccine interest for syphilis (OR = 2.02, 95% CI 1.29–3.19), chlamydia (OR = 2.41, 95% CI 1.50–3.90), and gonorrhea (OR = 2.29, 95% CI 1.44–3.63). Ever having sexual intercourse and identifying as LGBTQ were significantly associated with vaccine interest for all infections, while age and ever being immunosuppressed were not significant in any adjusted models. Findings indicate over 80% of participants in a cohort of young HPV-vaccinated Canadian women are interested in receiving future bacterial STI vaccines. Further exploration of STI vaccine acceptability among diverse populations is required to inform future bacterial STI vaccine program implementation.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"30 1","pages":"776 - 785"},"PeriodicalIF":0.0,"publicationDate":"2022-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85614567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-16DOI: 10.17269/s41997-022-00649-1
P. Sookaromdee, V. Wiwanitkit
Dear Editor: Reifferscheid et al. (2022) assert that vaccine safety is a major concern for the pregnant population in Canada, and that because disease risk is either poorly understood or poorly valued in this community, safety information should be provided to themwhen it becomes available, combinedwith clear messaging on the benefits of vaccination. There are a number of factors that could influence pregnant women’s acceptance of the COVID-19 vaccine. According to Blakeway et al. in a recent publication in the American Journal of Obstetrics & Gynecology (Blakeway et al., 2022), younger women, nonwhite ethnicity, and lower socioeconomic level were all linked to lower COVID-19 vaccination uptake. We believe that determining the elements that lead to COVID-19 vaccine fear is crucial. Essential demographic characteristics were shown to be significantly associated with willingness to obtain a COVID-19 vaccine in an Indian study (Khan et al., 2022). In that Indian study, vital demographic variables such as younger female gender, age groups, lack of any personal condition, lower education level, and present employment position were discovered to be significantly connected with desire to acquire a COVID-19 vaccine (Khan et al., 2022). In addition, various periods of time may have different immunization objectives. The purpose of seeking to vaccinate women alters over time, according to a prior Hong Kong inquiry (Xiao et al., 2022). In a more than 1-year follow-up, the transient changes in variables linked to COVID-19 vaccine aversion were detailed. There was no statistically significant link between chronic medical conditions and vaccination apprehension prior to and during the implementation of the mass immunization campaign, according to a Hong Kong investigation. Residents with chronic illnesses, on the other hand, were more dubious 2 to 5 months after the program began (Xiao et al., 2022). New vaccine efficacy and safety data, which could lead to increased trust or unbelief in the COVID-19 vaccine, as well as the outbreak’s local context, could all play a role. Xiao et al. emphasized the necessity of tracking COVID-19 vaccine reluctance and associated factors over time and changing promotion methods accordingly to increase vaccination uptake. The data in Reifferscheid et al.’s current investigation came from a brief time of observation (Reifferscheid et al., 2022). According to the data described above, a range of factors influence the pattern of reluctance, and the pattern may change over time. As a result, drawing a firm conclusion from a single study may prove difficult.
亲爱的编辑:Reifferscheid等人(2022)断言，疫苗安全是加拿大怀孕人群的一个主要问题，由于该社区对疾病风险的了解或重视程度较低，因此应在获得安全信息时向她们提供安全信息，并明确传达疫苗接种的益处。有许多因素可能影响孕妇对COVID-19疫苗的接受程度。根据Blakeway等人最近在《美国妇产科杂志》(Blakeway et al.， 2022)上发表的一篇文章，年轻女性、非白人种族和较低的社会经济水平都与较低的COVID-19疫苗接种率有关。我们认为，确定导致COVID-19疫苗恐惧的因素至关重要。印度的一项研究显示，基本人口统计学特征与获得COVID-19疫苗的意愿显著相关(Khan等人，2022年)。在印度的这项研究中，重要的人口统计变量，如年轻女性性别、年龄组、缺乏任何个人条件、较低的教育水平和目前的就业职位，被发现与获得COVID-19疫苗的愿望显著相关(Khan et al.， 2022)。此外，不同时期可能有不同的免疫目标。根据香港之前的一项调查，寻求为女性接种疫苗的目的随着时间的推移而改变(Xiao et al.， 2022)。在1年多的随访中，详细描述了与COVID-19疫苗厌恶相关的变量的短暂变化。根据香港的一项调查，在实施大规模免疫运动之前和期间，慢性疾病与接种疫苗的担忧之间没有统计学上的显著联系。另一方面，患有慢性疾病的居民在项目开始后2至5个月更加怀疑(Xiao et al.， 2022)。新的疫苗功效和安全性数据可能会导致对COVID-19疫苗的信任或不信任增加，以及疫情的当地背景，这些都可能发挥作用。Xiao等人强调有必要长期跟踪COVID-19疫苗不情愿及其相关因素，并相应地改变推广方法以增加疫苗接种率。Reifferscheid等人目前调查的数据来自短暂的观察(Reifferscheid et al.， 2022)。根据上述数据，一系列因素影响磁阻的模式，并且模式可能随时间而改变。因此，从一项研究中得出一个确定的结论可能是困难的。
{"title":"Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”","authors":"P. Sookaromdee, V. Wiwanitkit","doi":"10.17269/s41997-022-00649-1","DOIUrl":"https://doi.org/10.17269/s41997-022-00649-1","url":null,"abstract":"Dear Editor: Reifferscheid et al. (2022) assert that vaccine safety is a major concern for the pregnant population in Canada, and that because disease risk is either poorly understood or poorly valued in this community, safety information should be provided to themwhen it becomes available, combinedwith clear messaging on the benefits of vaccination. There are a number of factors that could influence pregnant women’s acceptance of the COVID-19 vaccine. According to Blakeway et al. in a recent publication in the American Journal of Obstetrics & Gynecology (Blakeway et al., 2022), younger women, nonwhite ethnicity, and lower socioeconomic level were all linked to lower COVID-19 vaccination uptake. We believe that determining the elements that lead to COVID-19 vaccine fear is crucial. Essential demographic characteristics were shown to be significantly associated with willingness to obtain a COVID-19 vaccine in an Indian study (Khan et al., 2022). In that Indian study, vital demographic variables such as younger female gender, age groups, lack of any personal condition, lower education level, and present employment position were discovered to be significantly connected with desire to acquire a COVID-19 vaccine (Khan et al., 2022). In addition, various periods of time may have different immunization objectives. The purpose of seeking to vaccinate women alters over time, according to a prior Hong Kong inquiry (Xiao et al., 2022). In a more than 1-year follow-up, the transient changes in variables linked to COVID-19 vaccine aversion were detailed. There was no statistically significant link between chronic medical conditions and vaccination apprehension prior to and during the implementation of the mass immunization campaign, according to a Hong Kong investigation. Residents with chronic illnesses, on the other hand, were more dubious 2 to 5 months after the program began (Xiao et al., 2022). New vaccine efficacy and safety data, which could lead to increased trust or unbelief in the COVID-19 vaccine, as well as the outbreak’s local context, could all play a role. Xiao et al. emphasized the necessity of tracking COVID-19 vaccine reluctance and associated factors over time and changing promotion methods accordingly to increase vaccination uptake. The data in Reifferscheid et al.’s current investigation came from a brief time of observation (Reifferscheid et al., 2022). According to the data described above, a range of factors influence the pattern of reluctance, and the pattern may change over time. As a result, drawing a firm conclusion from a single study may prove difficult.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"1 1","pages":"559 - 559"},"PeriodicalIF":0.0,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79860960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-05DOI: 10.17269/s41997-022-00647-3
Catherine St-Pierre, L. Braverman, Marie-France Dubois, M. Levasseur
{"title":"Correction to: Convivialité des municipalités canadiennes à l’égard des aînés : portrait et facteurs associés","authors":"Catherine St-Pierre, L. Braverman, Marie-France Dubois, M. Levasseur","doi":"10.17269/s41997-022-00647-3","DOIUrl":"https://doi.org/10.17269/s41997-022-00647-3","url":null,"abstract":"","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"44 1","pages":"647 - 647"},"PeriodicalIF":0.0,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91528225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-04DOI: 10.17269/s41997-022-00644-6
Hilary A. T. Caldwell, G. Faulkner, M. Tremblay, R. Rhodes, L. de Lannoy, S. Kirk, L. Rehman, S. Moore
Public health restrictions varied by region during the COVID-19 pandemic and reduced opportunities for children to be physically active. The purpose of this study was to assess regional differences in movement behaviours of Canadian children and youth during the second wave of the COVID-19 pandemic. A national sample of Canadian parents (n=1568; 58% women) of children and youth (5–17 years of age) completed an online survey. Participants were classified based on region of residence (British Columbia, Prairies, Ontario, Quebec, or Atlantic Canada). Differences in movement and play behaviours (physical activity, outdoor play, sleep, screen time) between children and youth living in different regions were examined. Compared to children and youth in Quebec (the region with the highest COVID-19 prevalence), children and youth in the Prairies (F(1,1563)=9.0, p=0.01) and Atlantic Canada (F(1,1563)=17.1, p<0.001) participated in more moderate-to-vigorous physical activity (MVPA). Compared to Quebec, living in Atlantic Canada increased the odds of meeting the MVPA guideline (odds ratio (OR)=2.1, p=0.02), living in Ontario decreased the odds of meeting the sleep guideline (OR=0.6, p=0.01), and living in Ontario (OR=0.7, p=0.04) or Atlantic Canada (OR=0.6, p=0.049) decreased the odds of meeting the screen time guideline. Children and youth in Atlantic Canada demonstrated smaller declines in outdoor play than their counterparts in Quebec. Movement and play behaviours varied between regions of Canada where the highest COVID-19 prevalence corresponded to lower odds of meeting the physical activity guidelines. Low compliance with 24-hour movement guidelines suggests that regional pandemic recovery plans need to prioritize opportunities for healthy movement.
{"title":"Regional differences in movement behaviours of children and youth during the second wave of the COVID-19 pandemic in Canada: follow-up from a national study","authors":"Hilary A. T. Caldwell, G. Faulkner, M. Tremblay, R. Rhodes, L. de Lannoy, S. Kirk, L. Rehman, S. Moore","doi":"10.17269/s41997-022-00644-6","DOIUrl":"https://doi.org/10.17269/s41997-022-00644-6","url":null,"abstract":"Public health restrictions varied by region during the COVID-19 pandemic and reduced opportunities for children to be physically active. The purpose of this study was to assess regional differences in movement behaviours of Canadian children and youth during the second wave of the COVID-19 pandemic. A national sample of Canadian parents (n=1568; 58% women) of children and youth (5–17 years of age) completed an online survey. Participants were classified based on region of residence (British Columbia, Prairies, Ontario, Quebec, or Atlantic Canada). Differences in movement and play behaviours (physical activity, outdoor play, sleep, screen time) between children and youth living in different regions were examined. Compared to children and youth in Quebec (the region with the highest COVID-19 prevalence), children and youth in the Prairies (F(1,1563)=9.0, p=0.01) and Atlantic Canada (F(1,1563)=17.1, p<0.001) participated in more moderate-to-vigorous physical activity (MVPA). Compared to Quebec, living in Atlantic Canada increased the odds of meeting the MVPA guideline (odds ratio (OR)=2.1, p=0.02), living in Ontario decreased the odds of meeting the sleep guideline (OR=0.6, p=0.01), and living in Ontario (OR=0.7, p=0.04) or Atlantic Canada (OR=0.6, p=0.049) decreased the odds of meeting the screen time guideline. Children and youth in Atlantic Canada demonstrated smaller declines in outdoor play than their counterparts in Quebec. Movement and play behaviours varied between regions of Canada where the highest COVID-19 prevalence corresponded to lower odds of meeting the physical activity guidelines. Low compliance with 24-hour movement guidelines suggests that regional pandemic recovery plans need to prioritize opportunities for healthy movement.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"31 1 1","pages":"535 - 546"},"PeriodicalIF":0.0,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91263039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-29DOI: 10.17269/s41997-022-00639-3
Busola Ayodele, Elaine Guo, A. Sweetman, G. Guindon
To describe the extent to which New Brunswick residents reported having drug insurance coverage supplementary to Canadian Medicare; to examine associations between socioeconomic and demographic characteristics, health status, language identity, and having reported such coverage; and to document any changes in coverage associated with the introduction of the New Brunswick Drug Plan in 2014. We used repeated cross-sectional data for New Brunswick from eight cycles of the Canadian Community Health Survey from 2007 to 2017 and undertook logistic regression analysis. We found statistically significant, substantial and policy-relevant socioeconomic differences in the reporting of prescription drug insurance coverage among those 25–64 years and those ≥ 65 years of age, and an increasing reliance on private drug insurance over time. We found that individuals in the second decile of household income were particularly vulnerable to reporting neither public nor private drug coverage. The introduction of the New Brunswick Drug Plan in 2014 does not appear to have led to increased public drug coverage; however, from 2014, the decreasing trend in public drug coverage appears to have ceased. Those who reported lower health status usually had lower odds of reporting private drug coverage but higher odds of reporting public drug coverage. Driven by differences in private coverage, we found that relative to anglophones, francophones were less likely to report any drug coverage. Our findings emphasize the shortcomings of drug insurance systems such as that introduced in New Brunswick and substantiate calls for a universal drug program. New Brunswick’s increasing reliance on private drug insurance is of concern and warrants additional research.
{"title":"Inequity in insurance coverage for prescription drugs in New Brunswick, Canada","authors":"Busola Ayodele, Elaine Guo, A. Sweetman, G. Guindon","doi":"10.17269/s41997-022-00639-3","DOIUrl":"https://doi.org/10.17269/s41997-022-00639-3","url":null,"abstract":"To describe the extent to which New Brunswick residents reported having drug insurance coverage supplementary to Canadian Medicare; to examine associations between socioeconomic and demographic characteristics, health status, language identity, and having reported such coverage; and to document any changes in coverage associated with the introduction of the New Brunswick Drug Plan in 2014. We used repeated cross-sectional data for New Brunswick from eight cycles of the Canadian Community Health Survey from 2007 to 2017 and undertook logistic regression analysis. We found statistically significant, substantial and policy-relevant socioeconomic differences in the reporting of prescription drug insurance coverage among those 25–64 years and those ≥ 65 years of age, and an increasing reliance on private drug insurance over time. We found that individuals in the second decile of household income were particularly vulnerable to reporting neither public nor private drug coverage. The introduction of the New Brunswick Drug Plan in 2014 does not appear to have led to increased public drug coverage; however, from 2014, the decreasing trend in public drug coverage appears to have ceased. Those who reported lower health status usually had lower odds of reporting private drug coverage but higher odds of reporting public drug coverage. Driven by differences in private coverage, we found that relative to anglophones, francophones were less likely to report any drug coverage. Our findings emphasize the shortcomings of drug insurance systems such as that introduced in New Brunswick and substantiate calls for a universal drug program. New Brunswick’s increasing reliance on private drug insurance is of concern and warrants additional research.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"54 1","pages":"504 - 518"},"PeriodicalIF":0.0,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78646339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-28DOI: 10.17269/s41997-022-00638-4
Isabelle Laurin, Félicia Brochu, Gabriel Bordeleau-Gervais
From April 2020, in sight of child care reopening, the Direction régionale de santé publique de Montréal (DRSPM) conducted a situational analysis with its child care (CC) partners in order to learn about the challenges they envisioned in their role in preventing and managing COVID-19. The CC partners requested access to preferred public health support. The DRSPM established a service consisting of three components: (1) telephone support available 6 to 7 days/week for CC managers facing a COVID-19 situation; (2) a regional committee combining four Montreal representatives of CC associations and one from the Ministère de la Famille; (3) prevention brigades formed by front-line health workers from the Centres intégrés universitaires de santé et de services sociaux (CIUSSS). This health promotion intervention (1) enabled CC services to handle the pandemic with better capability and confidence through facilitating access to accurate and positive information; (2) supported the commitment and collaboration of CC services by acting as a mediator between them and decision-makers; and (3) responded to the psychosocial needs of community members. This service helped to adjust public policy and promote community resilience by raising awareness of the importance of balancing COVID-19 prevention and the collateral impacts of the pandemic.
{"title":"Soutien au réseau des services de garde montréalais dans la prévention et la gestion de la COVID-19 : un service à 3 pôles","authors":"Isabelle Laurin, Félicia Brochu, Gabriel Bordeleau-Gervais","doi":"10.17269/s41997-022-00638-4","DOIUrl":"https://doi.org/10.17269/s41997-022-00638-4","url":null,"abstract":"From April 2020, in sight of child care reopening, the Direction régionale de santé publique de Montréal (DRSPM) conducted a situational analysis with its child care (CC) partners in order to learn about the challenges they envisioned in their role in preventing and managing COVID-19. The CC partners requested access to preferred public health support. The DRSPM established a service consisting of three components: (1) telephone support available 6 to 7 days/week for CC managers facing a COVID-19 situation; (2) a regional committee combining four Montreal representatives of CC associations and one from the Ministère de la Famille; (3) prevention brigades formed by front-line health workers from the Centres intégrés universitaires de santé et de services sociaux (CIUSSS). This health promotion intervention (1) enabled CC services to handle the pandemic with better capability and confidence through facilitating access to accurate and positive information; (2) supported the commitment and collaboration of CC services by acting as a mediator between them and decision-makers; and (3) responded to the psychosocial needs of community members. This service helped to adjust public policy and promote community resilience by raising awareness of the importance of balancing COVID-19 prevention and the collateral impacts of the pandemic.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"9 1","pages":"528 - 534"},"PeriodicalIF":0.0,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73300872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-27DOI: 10.17269/s41997-022-00641-9
L. Reifferscheid, E. K. Marfo, A. Assi, È. Dubé, N. MacDonald, S. Meyer, J. Bettinger, S. Driedger, J. Robinson, M. Sadarangani, S. E. Wilson, K. Benzies, S. Lemaire-Paquette, A. Gagneur, S. MacDonald
To investigate COVID-19 vaccine uptake and intent among pregnant people in Canada, and determine associated factors. We conducted a national cross-sectional survey among pregnant people from May 28 through June 7, 2021 (n = 193). Respondents completed a questionnaire to determine COVID-19 vaccine acceptance (defined as either received or intend to receive a COVID-19 vaccine during pregnancy), factors associated with vaccine acceptance, and rationale for accepting/not accepting the vaccine. Of 193 respondents, 57.5% (n = 111) reported COVID-19 vaccine acceptance. Among those who did not accept the vaccine, concern over vaccine safety was the most commonly cited reason (90.1%, n = 73), and 81.7% (n = 67) disagreed with receiving a vaccine that had not been tested in pregnant people. Confidence in COVID-19 vaccine safety (aOR 16.72, 95% CI: 7.22, 42.39), Indigenous self-identification (aOR 11.59, 95% CI: 1.77, 117.18), and employment in an occupation at high risk for COVID-19 exposure excluding healthcare (aOR 4.76, 95% CI: 1.32, 18.60) were associated with vaccine acceptance. Perceived personal risk of COVID-19 disease was not associated with vaccine acceptance in the multivariate model. Vaccine safety is a primary concern for this population. Safety information should be communicated to this population as it emerges, along with clear messaging on the benefits of vaccination, as disease risk is either poorly understood or poorly valued in this population.
{"title":"COVID-19 vaccine uptake and intention during pregnancy in Canada","authors":"L. Reifferscheid, E. K. Marfo, A. Assi, È. Dubé, N. MacDonald, S. Meyer, J. Bettinger, S. Driedger, J. Robinson, M. Sadarangani, S. E. Wilson, K. Benzies, S. Lemaire-Paquette, A. Gagneur, S. MacDonald","doi":"10.17269/s41997-022-00641-9","DOIUrl":"https://doi.org/10.17269/s41997-022-00641-9","url":null,"abstract":"To investigate COVID-19 vaccine uptake and intent among pregnant people in Canada, and determine associated factors. We conducted a national cross-sectional survey among pregnant people from May 28 through June 7, 2021 (n = 193). Respondents completed a questionnaire to determine COVID-19 vaccine acceptance (defined as either received or intend to receive a COVID-19 vaccine during pregnancy), factors associated with vaccine acceptance, and rationale for accepting/not accepting the vaccine. Of 193 respondents, 57.5% (n = 111) reported COVID-19 vaccine acceptance. Among those who did not accept the vaccine, concern over vaccine safety was the most commonly cited reason (90.1%, n = 73), and 81.7% (n = 67) disagreed with receiving a vaccine that had not been tested in pregnant people. Confidence in COVID-19 vaccine safety (aOR 16.72, 95% CI: 7.22, 42.39), Indigenous self-identification (aOR 11.59, 95% CI: 1.77, 117.18), and employment in an occupation at high risk for COVID-19 exposure excluding healthcare (aOR 4.76, 95% CI: 1.32, 18.60) were associated with vaccine acceptance. Perceived personal risk of COVID-19 disease was not associated with vaccine acceptance in the multivariate model. Vaccine safety is a primary concern for this population. Safety information should be communicated to this population as it emerges, along with clear messaging on the benefits of vaccination, as disease risk is either poorly understood or poorly valued in this population.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"38 1","pages":"547 - 558"},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91381233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-20DOI: 10.17269/s41997-022-00640-w
A. Lodge, Chantelle Partyka, Kelly Surbey
Substance use remains a pervasive public health issue throughout Canada, exerting substantial economic, social, and political pressure on health care systems, while impacting lives of affected individuals. The advent of COVID-19 has been doubly perilous; it restricts existing programming, while exacting a worsening toll on mental health and substance use fronts across the demographic landscape. In response to the crisis, the Mobile Withdrawal Management Service (MWMS) was established in 2019 through a Winnipeg-based community health centre. MWMS is a community-based outreach withdrawal service that supports individuals for up to 30 days. Clients may choose where services are accessed in the community, including their own home. For those without safe housing, short-term accommodation is offered. Additionally, Indigenous cultural support, peer support, trauma counselling, and linkage to primary care are available. The MWMS approach is resolutely patient-centred. The program meets people where they are at, both figuratively and literally. Agility and adaptability—particularly in the context of substance use treatment—is uniquely advantageous in maintaining service delivery to the broad demographic cross-section revealed in the data. Moreover, relative to inpatient detoxification services, MWMS holds significant potential for system-wide cost savings. The presented approach addresses a significant gap in addiction services. There is substantial capacity for both increased access and system savings with implementation of this approach. Furthermore, the principles behind the program are readily transferable to different contexts and easily modifiable to local conditions. There is particular potential for servicing hard-to-reach populations, with respect to both physical and social geography.
{"title":"A novel home- and community-based mobile outreach detoxification service for individuals identifying problematic substance use: implementation and program evaluation","authors":"A. Lodge, Chantelle Partyka, Kelly Surbey","doi":"10.17269/s41997-022-00640-w","DOIUrl":"https://doi.org/10.17269/s41997-022-00640-w","url":null,"abstract":"Substance use remains a pervasive public health issue throughout Canada, exerting substantial economic, social, and political pressure on health care systems, while impacting lives of affected individuals. The advent of COVID-19 has been doubly perilous; it restricts existing programming, while exacting a worsening toll on mental health and substance use fronts across the demographic landscape. In response to the crisis, the Mobile Withdrawal Management Service (MWMS) was established in 2019 through a Winnipeg-based community health centre. MWMS is a community-based outreach withdrawal service that supports individuals for up to 30 days. Clients may choose where services are accessed in the community, including their own home. For those without safe housing, short-term accommodation is offered. Additionally, Indigenous cultural support, peer support, trauma counselling, and linkage to primary care are available. The MWMS approach is resolutely patient-centred. The program meets people where they are at, both figuratively and literally. Agility and adaptability—particularly in the context of substance use treatment—is uniquely advantageous in maintaining service delivery to the broad demographic cross-section revealed in the data. Moreover, relative to inpatient detoxification services, MWMS holds significant potential for system-wide cost savings. The presented approach addresses a significant gap in addiction services. There is substantial capacity for both increased access and system savings with implementation of this approach. Furthermore, the principles behind the program are readily transferable to different contexts and easily modifiable to local conditions. There is particular potential for servicing hard-to-reach populations, with respect to both physical and social geography.","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"22 1","pages":"562 - 568"},"PeriodicalIF":0.0,"publicationDate":"2022-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72698144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-20DOI: 10.17269/s41997-022-00645-5
Q. Durand-Moreau
{"title":"The hidden occupational health burden of COVID: work-related cardiovascular diseases related to long working hours","authors":"Q. Durand-Moreau","doi":"10.17269/s41997-022-00645-5","DOIUrl":"https://doi.org/10.17269/s41997-022-00645-5","url":null,"abstract":"","PeriodicalId":9525,"journal":{"name":"Canadian Journal of Public Health","volume":"309 1","pages":"405 - 406"},"PeriodicalIF":0.0,"publicationDate":"2022-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77841216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：